Ron Squarer, CEO at ARRAY BIOPHARMA INC (ARRY), sold 830,588 shares at $10.73 ($9.0M) on 2017-12-18, disclosed to the SEC on 2017-12-19.
Open-market sale of $9.0M ARRY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.92 | 10,917 | $119K | 1.3% |
| 2 | $10.73 | 273,438 | $2.9M | 32.5% |
| 3 | $10.93 | 546,233 | $6.0M | 66.2% |
| Total | $10.86 avg | 830,588 | $9.0M | 100% |
| Filing → |
| ARRY | SELL | 2019-02-01 | $6.0M | — | Filing → |
| ARRY | SELL | 2018-06-29 | $6.6M | — | Filing → |
| ARRY | SELL | 2015-03-04 | $330K | — | Filing → |